Loading data
ACRSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.83 m USD | 18.72 m USD | 31.25 m USD | 29.75 m USD | 6.76 m USD |
| Cost of revenue | 2.09 m USD | 2.79 m USD | 3.42 m USD | 4.02 m USD | 4.71 m USD |
| Research and development expense | 52.65 m USD | 33.59 m USD | 98.38 m USD | 77.81 m USD | 43.81 m USD |
| Operating profit | -76.38 m USD | -141.93 m USD | -97.36 m USD | -89.85 m USD | -89.72 m USD |
| Profit before tax | -64.92 m USD | -132.07 m USD | -88.85 m USD | -86.91 m USD | -90.87 m USD |
| Income tax expense | — | — | -367 k USD | — | — |
| Net income (reported basis) | -64.92 m USD | -132.07 m USD | -88.48 m USD | -86.91 m USD | -90.87 m USD |
| Basic earnings per share | -0.53 USD/share | -1.71 USD/share | -1.27 USD/share | -1.33 USD/share | -1.6 USD/share |
| Diluted earnings per share | -0.53 USD/share | -1.71 USD/share | -1.27 USD/share | -1.33 USD/share | -1.6 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.